Mitochondrial ROS connects P2X7-mediated Ca²⁺ influx with IL-1α release by monocytes upon chronic tissue damage

Area of Science:

• Immunology
• Cell Biology
• Pathology

Background:

• Chronic inflammation contributes to tissue injury and disease progression.
• Monocytes play a key role in chronic inflammation by releasing proinflammatory cytokines.
• Understanding the molecular mechanisms driving monocyte-mediated inflammation is crucial for developing targeted therapies.

Purpose of the Study:

• To elucidate a novel mechanism by which monocytes contribute to chronic inflammation and tissue damage.
• To investigate the role of purinergic signaling in monocyte activation and cytokine release.
• To link this mechanism to specific disease pathologies such as chronic kidney disease and myocardial infarction.

Main Methods:

• The study investigated adenosine triphosphate (ATP)-induced activation of the purinergic P2X purinoceptor 7 (P2X7) receptor in monocytes.
• Researchers examined calcium ion-dependent mitochondrial reactive oxygen species (ROS) production following P2X7 activation.
• The study assessed the release of interleukin-1α (IL-1α) and its downstream effects in disease models.

Main Results:

• ATP-induced P2X7 receptor activation triggers calcium-dependent mitochondrial ROS production in monocytes.
• This process leads to the release of interleukin-1α (IL-1α) from monocytes.
• The study demonstrated that this IL-1α release stimulates immune cell infiltration and fibrosis in chronic kidney disease and promotes adverse cardiac remodeling post-myocardial infarction.

Conclusions:

• A novel pathway involving P2X7 receptor activation, mitochondrial ROS, and IL-1α release by monocytes drives chronic inflammation.
• This mechanism contributes significantly to tissue injury in chronic kidney disease and adverse cardiac remodeling after myocardial infarction.
• Targeting this purinergic signaling pathway may offer therapeutic strategies for inflammatory diseases.